These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12108991)

  • 1. What does it mean for patients? The expanded Medicare coverage of immunosuppressive medications.
    Thomas C
    Nephrol News Issues; 2001 May; Suppl():S15-7. PubMed ID: 12108991
    [No Abstract]   [Full Text] [Related]  

  • 2. Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.
    Bennett WM
    Clin J Am Soc Nephrol; 2010 May; 5(5):743. PubMed ID: 20448072
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare coverage changes force a DM approach to ESRD.
    Healthc Demand Dis Manag; 1998 Dec; 4(12):184-6. PubMed ID: 10339124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does MFD fit under Medicare coverage?
    Robers S
    Nephrol News Issues; 2001 May; 15(6):52-3, 55. PubMed ID: 12109003
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug coverage for transplantation turns into political football: big business trumps patients.
    Cohen DJ; Murphy B
    Clin J Am Soc Nephrol; 2010 May; 5(5):746-7. PubMed ID: 20448069
    [No Abstract]   [Full Text] [Related]  

  • 6. Insurance woes threaten gift of life.
    Harris P
    Nephrol News Issues; 2008 Aug; 22(9):48-9. PubMed ID: 18778007
    [No Abstract]   [Full Text] [Related]  

  • 7. Until we get lifetime coverage for immunosuppressive medications, the underground will thrive.
    Ester D
    Nephrol News Issues; 1999 Aug; 13(8):18. PubMed ID: 10765233
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposed conditions for coverage directed toward dialysis facilities.
    Smetanka S
    Health Care Law Mon; 2005 Apr; ():3-11. PubMed ID: 15895752
    [No Abstract]   [Full Text] [Related]  

  • 9. Medicare from A to D: what every nephrologist needs to know.
    Morrison L
    Clin J Am Soc Nephrol; 2008 May; 3(3):899-904. PubMed ID: 18372321
    [No Abstract]   [Full Text] [Related]  

  • 10. Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation.
    Gill JS; Tonelli M
    N Engl J Med; 2012 Feb; 366(7):586-9. PubMed ID: 22296029
    [No Abstract]   [Full Text] [Related]  

  • 11. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Payment for immunosuppression after organ transplantation. American Society of Transplantation.
    Kasiske BL; Cohen D; Lucey MR; Neylan JF
    JAMA; 2000 May; 283(18):2445-50. PubMed ID: 10815094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare now provides limited EECP (enhanced external counterpulsation) coverage.
    Patient Acc; 1999 Aug; 22(8):1, 3. PubMed ID: 10558026
    [No Abstract]   [Full Text] [Related]  

  • 15. Responding with a united voice to the Conditions of Coverage!
    VanBuskirk S
    Nephrol Nurs J; 2005; 32(3):266-7. PubMed ID: 16035469
    [No Abstract]   [Full Text] [Related]  

  • 16. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health insurance considerations for adolescent transplant recipients as they transition to adulthood.
    Willoughby LM; Fukami S; Bunnapradist S; Gavard JA; Lentine KL; Hardinger KL; Burroughs TE; Takemoto SK; Schnitzler MA
    Pediatr Transplant; 2007 Mar; 11(2):127-31. PubMed ID: 17300489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.
    Kadatz M; Gill JS; Gill J; Formica RN; Klarenbach S
    J Am Soc Nephrol; 2020 Jan; 31(1):218-228. PubMed ID: 31704739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financial aspects of organ transplantation.
    Ehlers SE
    Nephrol Nurs J; 2002 Jun; 29(3):285-91. PubMed ID: 12164079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.